个人科研网厅 | | 帮助
高级检索
当前位置： 首页 > 详情页

Sustained Remission and Decreased Severity of CAR T-Cell Related Adverse Events: A Pivotal Study Report of CNCT19 (inaticabtagene autoleucel) Treatment in Adult Patients with Relapsed/Refractory B-Cell Acute Lymphoblastic Leukemia (R/R B-Cell ALL) in China

| 认领 | 导出 | |

文献详情

资源类型：
WOS体系：

收录情况： ◇ SCIE ◇ CPCI(ISTP)

作者：
Wang, Ying[1,2] * ; Wei, Xudong[3] ; Yan, Dongmei[4] ; Zhang, Cheng[5] ; Zhou, Hongsheng[6] ; Tong, Chunrong[7] ; Mei, Heng[8] ; Jin, Jie[9] ; Niu, Ting[10] ; Liang, Aibin[11] ; Ren, Jienan[12] ; Deng, Yiping[12] ; Jin, Wei[12] ; Feng, Yi[12] ; Shi, Lin[12] ; Wang, Yongzeng[12] ; Haudenschild, Changting[12] ; Lv, Lulu[12] ; Wang, Jianxiang[1,2] ;
单位： [1]Chinese Acad Med Sci & Peking Union Med Coll, State Key Lab Expt Hematol, Natl Clin Res Ctr Blood Dis, Inst Hematol, Tianjin, Peoples R China [2]Chinese Acad Med Sci & Peking Union Med Coll, Blood Dis Hosp, Tianjin, Peoples R China [3]Zhengzhou Univ, Henan Canc Hosp, Affiliated Tumor Hosp, Dept Hematol, Zhengzhou, Peoples R China [4]Xuzhou Med Univ, Affiliated Hosp, Dept Hematol, Xuzhou, Jiangsu, Peoples R China [5]Army Med Univ, Xinqiao Hosp, Med Ctr Hematol, State Key Lab Trauma, Chongqing, Peoples R China [6]Southern Med Univ, Nanfang Hosp, Dept Hematol, Guangzhou, Peoples R China [7]Beijing Boren Hosp, Dept Hematol, Beijing, Peoples R China [8]Huazhong Univ Sci & Technol, Union Hosp, Tongji Med Coll, Dept Hematol, Wuhan, Peoples R China [9]Zhejiang Univ, Sch Med, Dept Hematol, Affiliated Hosp 1, Hangzhou, Peoples R China [10]Sichuan Univ, West China Hosp, Chengdu, Peoples R China [11]Tongji Univ, Tongji Hosp, Sch Med, Shanghai, Peoples R China [12]Juventas Cell Therapy Ltd, Tianjin, Peoples R China
出处：
DOI： 10.1182/blood-2022-165002
ISSN：
语种：
外文
被引次数：
WOS：
中科院(CAS)分区：
出版当年[2021]版：
大类 | 1 区 医学
小类 | 1 区 血液学
最新[2025]版：
大类 | 1 区 医学
小类 | 1 区 血液学
JCR分区：
出版当年[2020]版：
Q1 HEMATOLOGY
最新[2023]版：
Q1 HEMATOLOGY

影响因子： 最新[2023版] 最新五年平均 出版当年[2020版] 出版当年五年平均 出版前一年[2019版] 出版后一年[2021版]

第一作者：
第一作者单位： [1]Chinese Acad Med Sci & Peking Union Med Coll, State Key Lab Expt Hematol, Natl Clin Res Ctr Blood Dis, Inst Hematol, Tianjin, Peoples R China [2]Chinese Acad Med Sci & Peking Union Med Coll, Blood Dis Hosp, Tianjin, Peoples R China
推荐引用方式(GB/T 7714)：
Wang Ying,Wei Xudong,Yan Dongmei,et al.Sustained Remission and Decreased Severity of CAR T-Cell Related Adverse Events: A Pivotal Study Report of CNCT19 (inaticabtagene autoleucel) Treatment in Adult Patients with Relapsed/Refractory B-Cell Acute Lymphoblastic Leukemia (R/R B-Cell ALL) in China[J].BLOOD.2022,140:1598-1600.doi:10.1182/blood-2022-165002.
APA：
Wang, Ying,Wei, Xudong,Yan, Dongmei,Zhang, Cheng,Zhou, Hongsheng...&Wang, Jianxiang.(2022).Sustained Remission and Decreased Severity of CAR T-Cell Related Adverse Events: A Pivotal Study Report of CNCT19 (inaticabtagene autoleucel) Treatment in Adult Patients with Relapsed/Refractory B-Cell Acute Lymphoblastic Leukemia (R/R B-Cell ALL) in China.BLOOD,140,
MLA：
Wang, Ying,et al."Sustained Remission and Decreased Severity of CAR T-Cell Related Adverse Events: A Pivotal Study Report of CNCT19 (inaticabtagene autoleucel) Treatment in Adult Patients with Relapsed/Refractory B-Cell Acute Lymphoblastic Leukemia (R/R B-Cell ALL) in China".BLOOD 140.(2022):1598-1600

资源点击量：426 今日访问量：0 总访问量：410 更新日期：2025-04-01 建议使用谷歌、火狐浏览器 常见问题

版权所有：重庆聚合科技有限公司 渝ICP备12007440号-3 地址：重庆市两江新区泰山大道西段8号坤恩国际商务中心16层（401121）